The Effectiveness and Safety of Mucoadhesive Film Containing A.Oleracea Extract

NCT ID: NCT05219747

Last Updated: 2022-02-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-28

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Several natural products have been use to promote wound healing and relieve pain. Acmella oleracea has a component that has anesthetic and anti-inflammatory properties.

The mucoadhesive film can be improved by drug delivery system due to close contact with the absorption tissue leading to improvement in both local and systemic effects.

This study aims to evaluate the effectiveness and safety of mucoadhesive film containing Acmella oleracea extract in healthy subjects. This is a randomised, double-blind (participant and investigator), parallel-controlled clinical trial. In total, approximately 72 subjects will be enrolled into study.

Objectives

1. To investigate the potential of skin allergy reaction to mucoadhesive film containing Acmella oleracea extract in healthy subjects
2. To study the duration of mucosal adhesion of mucoadhesive film
3. To study the local anesthetic effect, participant's satisfaction and adverse effect of mucoadhesive film containing Acmella oleracea extract

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Total 72 Participants will divided into 2 groups by dentist who was not an examiner performed the randomization using blocked randomization (block of 4) from program of https://www.sealedenvelope.com/simple-randomiser/v1/lists/1. Study group will receive mucoadhesive film containing Acmella oleracea extract while control group will receive mucoadhesive film without active component. All participants in the study group will be test for allergic reaction of mucoadhesive film by skin prick test and patch skin test before testing and have to follow-up appointments (at 2, 4 and 7 days after skin test). At first visit, all participants will received oral examination and informed how to use mucoadhesive film by examiner. Then participants will asked to apply the mucoadhesive film at oral mucosa of lower lip. The effectiveness of intra-oral mucoadhesive film in this study will evaluated as follows :

1. Duration of mucosal adhesion and adverse effect by self report
2. The local anesthetic effect by using Numeric rating scale (NRS)
3. Participant's satisfaction by using Numeric rating scale (NRS)

The statistical methods :

General and oral health data, duration of mucosal adhesion will reported as frequencies, percentages and means (Standard deviation). The different of NRS score between groups will analyzed Independent t- test or Mann-Whitney U test. Using SPSS software. Statistically significant will considered at p-value \< 0.05.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oral Mucosa

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomize control trial
Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A.Oleracea group

Mucoadhesive film containing Acmella oleracea extract

Group Type EXPERIMENTAL

Mucoadhesive film containing Acmella oleracea extract

Intervention Type OTHER

Participants will apply a mucoadhesive film containing Acmella oleracea extract on labial mucosa of lower lip by themselves at least for 2 hours

Placebo group

Mucoadhesive film without Acmella oleracea extract

Group Type PLACEBO_COMPARATOR

Mucoadhesive film without Acmella oleracea extract

Intervention Type OTHER

Participants will apply a mucoadhesive film on labial mucosa of lower lip by themselves at least for 2 hours

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mucoadhesive film containing Acmella oleracea extract

Participants will apply a mucoadhesive film containing Acmella oleracea extract on labial mucosa of lower lip by themselves at least for 2 hours

Intervention Type OTHER

Mucoadhesive film without Acmella oleracea extract

Participants will apply a mucoadhesive film on labial mucosa of lower lip by themselves at least for 2 hours

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Healthy people age 18-60 years old and do not have regular medication.
2. Able to give the consent formation in a study and to cooperate in answering questionnaires or data records in google formation.
3. The participants must not have any wounds, tattoos, inflammation or pathology on the oral mucosa and skin of testing area.
4. The participants who can come to follow up for a specified period of time.

Exclusion Criteria

1. The participants who need dental treatment or necessary to use topical medication to treat oral diseases during the study period (7 days).
2. History of allergic to the components of mucoadhesive film and/or have a history of other allergies.
3. The vulnerable participants include pregnancy or lactating women and disabilities.
4. History of using antihistamines drugs during the one-week period prior to joining the study or participants who need to use such antihistamines during the time participating in the study.
5. History of using topical gluco-corticosteroids during the one-week period on skin testing areas.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Khon Kaen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kemporn Kitsahawong

Associated professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kemporn Kitsahawong, DDS,MSc,PhD

Role: PRINCIPAL_INVESTIGATOR

Faculty of Dentistry, Khon Kaen University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Dentistry , Khon Kaen University

Khon Kaen, , Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kemporn Kitsahawong, DDS,MSc,PhD

Role: CONTACT

0910566996

Patimaporn Pungchanchaikul, DDS,PhD

Role: CONTACT

0818299182

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KKUHE641398

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.